| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | |
|---|---|---|---|---|---|---|
Collaboration revenue | ||||||
26,517 | 53,589 | 48,058 | 49,856 | 50,319 | 51,954 | |
Expenses | ||||||
Research and development | ||||||
128,109 | 97,288 | 71,273 | 39,453 | 35,141 | 34,305 | |
Reacquired license rights | ||||||
124,398 | - | - | - | - | - | |
General and administrative | ||||||
58,298 | 32,748 | 23,260 | 16,603 | 13,693 | 11,512 | |
Depreciation | ||||||
932 | 431 | 437 | 682 | 1,819 | 2,512 | |
Total expenses | ||||||
311,737 | 130,467 | 94,970 | 56,738 | 50,653 | 48,329 | |
Investment income | ||||||
- | - | - | 214 | 32 | 43 | |
Other income (expense), net | ||||||
-4,942 | -3,642 | -756 | 214 | 32 | 43 | |
Loss before taxes on income | ||||||
-290,162 | -80,520 | -47,668 | -6,668 | -302 | 3,668 | |
(Benefit from) provision for taxes on income | ||||||
8 | 26 | 3 | -441 | 1,148 | 2,979 | |
Net loss | ||||||
-290,170 | -80,546 | -47,671 | -6,227 | -1,450 | 689 | |
Net loss per share—basic and diluted | ||||||
-9.54 | -2.91 | -1.99 | -0.31 | -0.09 | - | |
Weighted-average number of common shares used in net loss per share basic and diluted | ||||||
30,414 | 27,701 | 23,933 | 19,816 | 15,974 | - | |
Net (loss) income per share—basic | ||||||
- | - | - | - | - | 0.04 | |
Net (loss) income per share—diluted | ||||||
- | - | - | - | - | 0.04 | |
Weighted-average number of common shares used in net (loss) income per share basic | ||||||
- | - | - | - | - | 15,950 | |
Weighted-average number of common shares used in net (loss) income per share diluted | ||||||
- | - | - | - | - | 15,979 | |
License and milestone | ||||||
Collaboration revenue | ||||||
25,276 | 52,351 | 47,103 | 49,730 | 50,295 | 51,368 | |
Other revenue | ||||||
Collaboration revenue | ||||||
1,241 | 1,238 | 955 | 126 | 24 | 586 | |